ISDA

Deposition Date 2021-01-06

Release Date 2021-03-17

Last Version Date 2024-11-20

Entry Detail

PDB ID:

7LAA

Keywords:

VIRAL PROTEIN, IMMUNE SYSTEM

Title:

Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041

Biological Source:

Source Organism:

Severe acute respiratory syndrome coronavirus 2 (Taxon ID: 2697049)
Homo sapiens (Taxon ID: 9606)

Host Organism:

Homo sapiens

Method Details:

Experimental Method:

ELECTRON MICROSCOPY

Resolution:

3.42 Å

Aggregation State:

PARTICLE

Reconstruction Method:

SINGLE PARTICLE

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Spike glycoprotein
Gene (Uniprot):S
Chain IDs:A, B, E (auth: C)
Chain Length:1121
Number of Molecules:3
Biological Source:Severe acute respiratory syndrome coronavirus 2

UniProt ID:P0DTC2 Pfam ID:PF16451, PF09408, PF19209, PF01601

Polymer Type:polypeptide(L)
Molecule:DH1041 heavy chain
Chain IDs:C (auth: H)
Chain Length:226
Number of Molecules:1
Biological Source:Homo sapiens

Polymer Type:polypeptide(L)
Molecule:DH1041 light chain
Chain IDs:D (auth: L)
Chain Length:217
Number of Molecules:1
Biological Source:Homo sapiens

Ligand Molecules

NAG

Primary Citation

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.

Li, D, Edwards, R.J, Manne, K, Martinez, D.R, Schafer, A, Alam, S.M, Wiehe, K, Lu, X, Parks, R, Sutherland, L.L, Oguin 3rd, T.H, McDanal, C, Perez, L.G, Mansouri, K, Gobeil, S.M.C, Janowska, K, Stalls, V, Kopp, M, Cai, F, Lee, E, Foulger, A, Hernandez, G.E, Sanzone, A, Tilahun, K, Jiang, C, Tse, L.V, Bock, K.W, Minai, M, Nagata, B.M, Cronin, K, Gee-Lai, V, Deyton, M, Barr, M, Von Holle, T, Macintyre, A.N, Stover, E, Feldman, J, Hauser, B.M, Caradonna, T.M, Scobey, T.D, Rountree, W, Wang, Y, Moody, M.A, Cain, D.W, DeMarco, C.T, Denny, T.N, Woods, C.W, Petzold, E.W, Schmidt, A.G, Teng, I.T, Zhou, T, Kwong, P.D, Mascola, J.R, Graham, B.S, Moore, I.N, Seder, R, Andersen, H, Lewis, M.G, Montefiori, D.C, Sempowski, G.D, Baric, R.S, Acharya, P, Haynes, B.F, Saunders, K.O, Li, D, Edwards, R.J, Manne, K, Martinez, D.R, Schafer, A, Alam, S.M, Wiehe, K, Lu, X, Parks, R, Sutherland, L.L, Oguin, T.H, McDanal, C, Perez, L.G, Mansouri, K, Gobeil, S.M.C, Janowska, K, Stalls, V, Kopp, M, Cai, F, Lee, E, Foulger, A, Hernandez, G.E, Sanzone, A, Tilahun, K, Jiang, C, Tse, L.V, Bock, K.W, Minai, M, Nagata, B.M, Cronin, K, Gee-Lai, V, Deyton, M, Barr, M, Von Holle, T, Macintyre, A.N, Stover, E, Feldman, J, Hauser, B.M, Caradonna, T.M, Scobey, T.D, Moody, M.A, Cain, D.W, DeMarco, C.T, Denny, T.N, Woods, C.W, Petzold, E.W, Schmidt, A.G, Teng, I.T, Zhou, T, Kwong, P.D, Mascola, J.R, Graham, B.S, Moore, I.N, Seder, R, Andersen, H, Lewis, M.G, Montefiori, D.C, Sempowski, G.D, Baric, R.S, Acharya, P, Haynes, B.F, Saunders, K.O.Show

Cell 184 4203 ? (2021)

PMID: 34242577 DOI: 10.1016/j.cell.2021.06.021

Abstact

SARS-CoV-2-neutralizing antibodies (NAbs) protect against COVID-19. A concern regarding SARS-CoV-2 antibodies is whether they mediate disease enhancement. Here, we isolated NAbs against the receptor-binding domain (RBD) or the N-terminal domain (NTD) of SARS-CoV-2 spike from individuals with acute or convalescent SARS-CoV-2 or a history of SARS-CoV infection. Cryo-electron microscopy of RBD and NTD antibodies demonstrated function-specific modes of binding. Select RBD NAbs also demonstrated Fc receptor-γ (FcγR)-mediated enhancement of virus infection in vitro, while five non-neutralizing NTD antibodies mediated FcγR-independent in vitro infection enhancement. However, both types of infection-enhancing antibodies protected from SARS-CoV-2 replication in monkeys and mice. Three of 46 monkeys infused with enhancing antibodies had higher lung inflammation scores compared to controls. One monkey had alveolar edema and elevated bronchoalveolar lavage inflammatory cytokines. Thus, while in vitro antibody-enhanced infection does not necessarily herald enhanced infection in vivo, increased lung inflammation can rarely occur in SARS-CoV-2 antibody-infused macaques.

Legend

Protein

Chemical

Disease

Primary Citation of related structures